Skip to main content
. 2022 Dec 15;12:26335565221145493. doi: 10.1177/26335565221145493

Table 1.

The key stakeholder groups that will be engaged to provide feedback on the current experience of structured medication reviews and to undertake iterative review of prototype prescribing tools.

Stakeholder Contributors
General Practitioners General Practitioner trainees, locums, salaried and partner all welcome.
Secondary care clinicians Specialty input from clinical pharmacologists, psychiatrists and those working in geriatric medicine particularly. Senior trainee and consultant level.
Pharmacists All grades, spread of primary care and hospital practice/experience
Patient/Carers Representatives of key target groups including older people (65+) with frailty, multimorbidity, polypharmacy, mental and physical health disorders, caring responsibility for people with complex needs
Commissioner of services/managers/policy makers This will include representatives from a broad range of professionals working in the design, funding and governance of health services. This includes health & care system wide partners involved in the development of National Health Service England’s Integrated Care Systems – including commissioning, care quality management, health and social care provider, digital infrastructure and population health management perspectives.